on 10 Dec 2019
Last Applicant/ Owned by
4242 Campus Point Court, Suite 200
San Diego
CA
92121
Serial Number
87893278 filed on 25th Apr 2018
Registration Number
5932962 registered on 10th Dec 2019
Correspondent Address
BETH M. GOLDMAN
ORRICK, HERRINGTON & SUTCLIFFE LLP
2050 Main Street, Suite 1100
IP Prosecution Department
IRVINE, CA 92614-8255
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"APREPITANT INJECTABLE EMULSION"
"APREPITANT INJECTABLE EMULSION" Color is not claimed as a feature of the mark. Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular Read More
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
22nd Oct 2019
22nd Oct 2019
No 87893278
No Service/Collective Mark
No 21539-6000
No
No
No
No
No
No
No
No
26.05.21 -
Triangles that are completely or partially shaded
The mark consists of a stylized triangle centered to the left of the word "CINVANTI" in bold stylized lettering above the words "(APREPITANT) INJECTABLE EMULSION" in stylized lettering.
Status Date | Action Taken |
---|---|
16th Aug 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
10th Dec 2019 | REGISTERED-PRINCIPAL REGISTER |
06th Nov 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
05th Nov 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
30th Oct 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
29th Oct 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
29th Oct 2019 | SOU EXTENSION 2 GRANTED |
29th Oct 2019 | STATEMENT OF USE PROCESSING COMPLETE |
24th Oct 2019 | TEAS STATEMENT OF USE RECEIVED |
24th Oct 2019 | SOU TEAS EXTENSION RECEIVED |